BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $220,000 | -9.8% | 2,840 | 0.0% | 0.03% | -3.0% |
| Q4 2021 | $244,000 | +7.0% | 2,840 | 0.0% | 0.03% | -2.9% |
| Q3 2021 | $228,000 | -5.8% | 2,840 | -5.3% | 0.03% | -5.6% |
| Q2 2021 | $242,000 | -39.7% | 3,000 | -36.8% | 0.04% | -43.8% |
| Q1 2021 | $401,000 | -0.2% | 4,750 | -5.1% | 0.06% | -4.5% |
| Q4 2020 | $402,000 | -0.2% | 5,005 | 0.0% | 0.07% | -11.8% |
| Q3 2020 | $403,000 | -21.4% | 5,005 | -16.0% | 0.08% | -27.6% |
| Q2 2020 | $513,000 | +4.7% | 5,955 | -1.2% | 0.10% | -8.7% |
| Q1 2020 | $490,000 | -2.8% | 6,030 | 0.0% | 0.12% | +21.1% |
| Q4 2019 | $504,000 | +10.0% | 6,030 | +15.1% | 0.10% | +4.4% |
| Q3 2019 | $458,000 | +21.8% | 5,240 | +14.2% | 0.09% | +18.2% |
| Q2 2019 | $376,000 | -1.3% | 4,590 | -2.1% | 0.08% | -4.9% |
| Q1 2019 | $381,000 | +21.0% | 4,690 | -2.1% | 0.08% | +6.6% |
| Q4 2018 | $315,000 | -14.6% | 4,790 | 0.0% | 0.08% | -5.0% |
| Q3 2018 | $369,000 | +25.1% | 4,790 | +20.1% | 0.08% | +15.9% |
| Q2 2018 | $295,000 | +13.5% | 3,990 | 0.0% | 0.07% | +11.3% |
| Q1 2018 | $260,000 | +0.8% | 3,990 | 0.0% | 0.06% | -12.7% |
| Q4 2017 | $258,000 | -0.4% | 3,990 | -3.4% | 0.07% | -9.0% |
| Q3 2017 | $259,000 | +3.6% | 4,130 | 0.0% | 0.08% | -2.5% |
| Q2 2017 | $250,000 | +16.8% | 4,130 | 0.0% | 0.08% | +11.1% |
| Q1 2017 | $214,000 | -48.2% | 4,130 | -61.9% | 0.07% | -44.2% |
| Q4 2015 | $413,000 | +17.3% | 10,830 | +0.9% | 0.13% | +9.3% |
| Q3 2015 | $352,000 | -51.0% | 10,730 | +4.6% | 0.12% | -47.1% |
| Q2 2015 | $718,000 | +3.3% | 10,260 | +1.1% | 0.22% | +1.4% |
| Q1 2015 | $695,000 | +15.4% | 10,150 | +23.6% | 0.22% | +16.4% |
| Q4 2014 | $602,000 | +14.9% | 8,210 | +12.5% | 0.19% | +8.6% |
| Q3 2014 | $524,000 | -0.8% | 7,300 | 0.0% | 0.17% | -1.7% |
| Q2 2014 | $528,000 | -1.9% | 7,300 | 0.0% | 0.18% | -7.3% |
| Q1 2014 | $538,000 | +5.9% | 7,300 | 0.0% | 0.19% | +6.1% |
| Q4 2013 | $508,000 | +6.3% | 7,300 | +0.3% | 0.18% | -3.7% |
| Q3 2013 | $478,000 | -0.8% | 7,280 | +4.6% | 0.19% | -7.0% |
| Q2 2013 | $482,000 | – | 6,960 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |